Abstract
The development of cancer is a pathological process involving multiple environmental carcinogenic factors and genetic alterations. For decades, cancer researchers have focused on genomic and transcriptomic analyses. The completion of the Human Genome Project has opened the door to the post-genome era and oncoproteomics. Proteins play a critical role in tumorigenesis and influence the differences between normal cells and malignant cells. This report proposes the concept that cancer is a proteomic disease. This concept is based on examining protein expression profiles, post-translational modifications, and protein-protein interactions in carcinogenesis using recent advances in comparative, functional and structural proteomics. This approach provides a new way of viewing carcinogenesis, presents new clues in biomarker discovery for cancer diagnosis and therapy, and reveals important scientific findings and their significance to clinical applications.
Article PDF
Similar content being viewed by others
References
Zeng Y, Lu Y, Zhu M, et al. Oncology. 2nd ed. Beijing: People Health Publishing House, 2003. 11–30
Chen Z, Liang S, Xiao Z, et al. Cancer Proteomics. Changsha: Hunan Science and Technology Press, 2002. 1–9
Li F, Li M, Xiao Z, et al. Construction of a nasopharyngeal carcinoma 2D/MS repository with Open Source XML Database—Xindice. BMC Bioinformatics, 2006, 7: 13 16403238, 10.1186/1471-2105-7-13
Li F, Xiao Z, Zhang P, et al. A reference map of human nasopharyngeal squamous carcinoma proteome. Int J Oncol, 2007, 30: 1077–1088 17390009, 1:CAS:528:DC%2BD2sXlsVCmsrw%3D
Cheng A L, Huang W G, Chen Z C, et al. Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis. J Proteome Res, 2008, 7: 2415–2426 18433155, 10.1021/pr7008548, 1:CAS:528:DC%2BD1cXltVeis78%3D
Hsieh S Y, Zhuang F H, Wu Y T, et al. Profiling the proteome dynamics during the cell cycle of human hepatoma cells. Proteomics, 2008, 8: 2872–2884 18655025, 10.1002/pmic.200800196, 1:CAS:528:DC%2BD1cXpslWnsL4%3D
Young T W, Mei F C, Yang G, et al. Activation of antioxidant pathways in ras-mediated oncogenic transformation of human surface ovarian epithelial cells revealed by functional proteomics and mass spectrometry. Cancer Res, 2004, 64: 4577–4584 15231669, 10.1158/0008-5472.CAN-04-0222, 1:CAS:528:DC%2BD2cXltlOrsbo%3D
Imamura T, Kanai F, Kawakami T, et al. Proteomic analysis of the TGF-β signaling pathway in pancreatic carcinoma cells using stable RNA interference to silence Smad4 expression. Biochem Biophys Res Commun, 2004, 318: 289–296 15110786, 10.1016/j.bbrc.2004.04.029, 1:CAS:528:DC%2BD2cXjsVWlur8%3D
Qattan A T, Mulvey C, Crawford M, et al. Quantitative organelle proteomics of MCF-7 breast cancer cells reveals multiple subcellular locations for proteins in cellular functional processes. J Proteome Res, 2010, 9: 495–508 19911851, 10.1021/pr9008332, 1:CAS:528:DC%2BD1MXhsFant7fE
Leth-Larsen R, Lund R, Hansen H V, et al. Metastasis-related plasma membrane proteins of human breast cancer cells identified by comparative quantitative mass spectrometry. Mol Cell Proteomics, 2009, 8: 1436–1449 19321434, 10.1074/mcp.M800061-MCP200, 1:CAS:528:DC%2BD1MXhtVegurnI
Leth-Larsen R, Lund R R, Ditzel H J. Plasma membrane proteomics and its application in clinical cancer biomarker discovery. Mol Cell Proteomics, 2010, 9: 1369–1382 20382631, 10.1074/mcp.R900006-MCP200, 1:CAS:528:DC%2BC3cXhtlGltL3P
Xiao Z, Li G, Chen Y, et al. Quantitative proteomic analysis of formalin-fixed and paraffin-embedded nasopharyngeal carcinoma using iTRAQ labeling, two-dimensional liquid chromatography, and tandem mass spectrometry. J Histochem Cytochem, 2010, 58: 517–527 20124091, 10.1369/jhc.2010.955526, 1:CAS:528:DC%2BC3cXms1Sjs70%3D
Habermann J K, Paulsen U, Roblick U J, et al. Stage-specific alterations of the genome, transcriptome, and proteome during colorectal carcinogenesis. Genes Chromosomes Cancer, 2007, 46: 10–26 17044061, 10.1002/gcc.20382, 1:CAS:528:DC%2BD28Xht1GntrjF
Wu X Y, Li C, Xiao Z Q, et al. 2-DE profiling and differential analysis of human bronchial epithelial tissues in different stages of carcinogenesis. Chin J Cancer, 2004, 23: 522–530 1:CAS:528:DC%2BD2MXhvVWltA%3D%3D
Chen J, Kahne T, Rocken C, et al. Proteome analysis of gastric cancer metastasis by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of metastasis-related proteins. J Proteome Res, 2004, 3: 1009–1016 15473690, 10.1021/pr049916l, 1:CAS:528:DC%2BD2cXmtFOrtLw%3D
Choong L Y, Lim S, Chong P K, et al. Proteome-wide profiling of the MCF10AT breast cancer progression model. PLoS One, 2010, 5: e11030 20543960, 10.1371/journal.pone.0011030
Li C, Xiao Z, Chen Z, et al. Proteome analysis of human lung squamous carcinoma. Proteomics, 2006, 6: 547–558 16342241, 10.1002/pmic.200500256, 1:CAS:528:DC%2BD28Xhs1ehtL8%3D
Liu Y F, Xiao Z Q, Li M X, et al. Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma. J Pathol, 2009, 217: 54–64 18798225, 10.1002/path.2429, 1:CAS:528:DC%2BD1MXhsVaru70%3D
Zhang Z, Bast R C Jr, Yu Y, et al. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res, 2004, 64: 5882–5890 15313933, 10.1158/0008-5472.CAN-04-0746, 1:CAS:528:DC%2BD2cXmslaks7Y%3D
Mor G, Visintin I, Lai Y, et al. Serum protein markers for early detection of ovarian cancer. Proc Natl Acad Sci USA, 2005, 102: 7677–7682 15890779, 10.1073/pnas.0502178102, 1:CAS:528:DC%2BD2MXkslOmsrk%3D
Liu J, Wang J, Qian X, et al. Technique strategies of modification-specific proteomics study. Chin J Biochem Mol Biol, 2007, 23: 93–100
Whelan S A, Lu M, He J, et al. Mass spectrometry (LC-MS/MS) site-mapping of N-glycosylated membrane proteins for breast cancer biomarkers. J Proteome Res, 2009, 8: 4151–4160 19522481, 10.1021/pr900322g, 1:CAS:528:DC%2BD1MXos1Ons7g%3D
Chaerkady R, Thuluvath P J, Kim M S, et al.18O labeling for a quantitative proteomic analysis of glycoproteins in hepatocellular carcinoma. Clin Proteomics, 2008, 4: 137–155 20357908, 10.1007/s12014-008-9013-0, 1:CAS:528:DC%2BD1cXhtlKis73E
Wang N, Kang X, Liu Y, et al. Membrane protein glycanprofiling of hepatocellular carcinoma cell with different metastastic potential by lectin microarray. Prog Biochem Biophys, 2009, 36: 1348–1355 10.3724/SP.J.1206.2009.00120, 1:CAS:528:DC%2BC3cXhsVGhurs%3D
Li H, Ren Z, Kang X, et al. Identification of tyrosine-phosphorylated proteins associated with metastasis and functional analysis of FER in human hepatocellular carcinoma cells. BMC Cancer, 2009, 9: 366 19835603, 10.1186/1471-2407-9-366
Ruan L, Wang G L, Chen Y, et al. Identification of tyrosine phosphoproteins in signaling pathway triggered TGF-α by using functional proteomics technology. Med Oncol, 2010, 27: 1407–1414 20049563, 10.1007/s12032-009-9394-6, 1:CAS:528:DC%2BC3cXhsVGrt7nK
Akashi T, Nishimura Y, Wakatabe R, et al. Proteomics-based identification of biomarkers for predicting sensitivity to a PI3-kinase inhibitor in cancer. Biochem Biophys Res Commun, 2007, 352: 514–521 17137555, 10.1016/j.bbrc.2006.11.052, 1:CAS:528:DC%2BD28XhtlShsr3L
Akashi T, Yamori T. Proteomic analysis of phosphoproteins sensitive to a phosphatidylinositol 3-kinase inhibitor, ZSTK474, by using SELDI-TOF MS. Proteome Sci, 2009, 7: 14 19331694, 10.1186/1477-5956-7-14
Vasilescu J, Smith J C, Ethier M, et al. Proteomic analysis of ubiquitinated proteins from human MCF-7 breast cancer cells by immunoaffinity purification and mass spectrometry. J Proteome Res, 2005, 4: 2192–2200 16335966, 10.1021/pr050265i, 1:CAS:528:DC%2BD2MXhtFegs7vF
Meierhofer D, Wang X, Huang L, et al. Quantitative analysis of global ubiquitination in HeLa cells by mass spectrometry. J Proteome Res, 2008, 7: 4566–4576 18781797, 10.1021/pr800468j, 1:CAS:528:DC%2BD1cXhtV2hs7rN
Stumpf M P, Thorne T, de Silva E, et al. Estimating the size of the human interactome. Proc Natl Acad Sci USA, 2008, 105: 6959–6964 18474861, 10.1073/pnas.0708078105, 1:CAS:528:DC%2BD1cXmt1Gitrg%3D
Jonsson P F, Bates P A. Global topological features of cancer proteins in the human interactome. Bioinformatics, 2006, 22: 2291–2297 16844706, 10.1093/bioinformatics/btl390, 1:CAS:528:DC%2BD28Xps1ynsrk%3D
Yokoo H, Kondo T, Fujii K, et al. Proteomic signature corresponding to alpha fetoprotein expression in liver cancer cells. Hepatology, 2004, 40: 609–617 15349899, 10.1002/hep.20372, 1:CAS:528:DC%2BD2cXot1Ort7g%3D
Hu W, Xiao Z, Chen Z, et al. Separation and identification of p53 interacting proteins from human nasopharyngeal carcinoma cells. Prog Biochem Biophys, 2004, 31: 628–634 1:CAS:528:DC%2BD28Xitl2nt74%3D
Sun Y, Yi H, Zhang P F, et al. Identification of differential proteins in nasopharyngeal carcinoma cells with p53 silence by proteome analysis. FEBS Lett, 2007, 581: 131–139 17184779, 10.1016/j.febslet.2006.12.008, 1:CAS:528:DC%2BD2sXht1Wkug%3D%3D
Tu L C, Yan X, Hood L, et al. Proteomics analysis of the interactome of N-myc downstream regulated gene 1 and its interactions with the androgen response program in prostate cancer cells. Mol Cell Proteomics, 2007, 6: 575–588 17220478, 10.1074/mcp.M600249-MCP200, 1:CAS:528:DC%2BD2sXksVKgtb0%3D
Patwardhan A J, Strittmatter E F, Camp D G II, et al. Comparison of normal and breast cancer cell lines using proteome, genome, and interactome data. J Proteome Res, 2005, 4: 1952–1960 16335939, 10.1021/pr0501315, 1:CAS:528:DC%2BD2MXhtVegt7fE
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published with open access at Springerlink.com
Rights and permissions
Open Access This is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License (https://creativecommons.org/licenses/by-nc/2.0), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
About this article
Cite this article
Li, G., Xiao, Z., Liu, J. et al. Cancer: A proteomic disease. Sci. China Life Sci. 54, 403–408 (2011). https://doi.org/10.1007/s11427-011-4163-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-011-4163-0